Escolar Documentos
Profissional Documentos
Cultura Documentos
AMILASE CINÉTICA
K046
INSTRUÇÕES DE USO
AMILASA CINÉTICA
K046
INSTRUCCIONES DE USO
AMYLASE KINETIC
K046
USAGE INSTRUCTIONS
FUNCTION biological material can be made in accordance with current Urine
Method for determination of the α-Amylase. Kinetic legislation. Amylase (U/L) = DA/min. x 3954
test, only for in vitro diagnostic use. 9- To obtain information related to biosafety or in
case of accidents with the product, consult the MSDS Urinary Amylase (U/h) = (Amylase (U/L) x V)
PRINCIPLE OF ACTION (Material Safety Data Sheet) available on the website (H x 1000)
Methodology: Kinetic www.bioclin.com.br or upon request by the SAC (Customer
The α-Amylase catalyzes the hydrolysis of the α-(2- Advisory Service) of Quibasa. V = Urinary volume in mL
Chloro-4-Nitrophenyl)-β-1,4-Galactopiranosilmaltoside 10- Do not use the product in case of damaged packaging. H = Hours from urine collection
11- It is essential that the instruments and equipments used
(Gal-G2-α-CNP) releasing 2-Chloro-4-Nitrophenol (CNP)
are properly calibrated and subjected to periodic maintenance. Example
and 1,4 Galactopiranosilmaltoside (Gal-G2). The catalyst
concentration is determined from the rate of 2-Chloro-4- Urinary Amylase (value found in the dosage) = 90 U/L
SAMPLES V = 200 mL
Nitrophenol formation, measured at 405 nm. Serum obtained free of hemolysis, plasma with Heparin, H=2
α-Amylase
Urine and cavitary fluids (ascitic, duodenal and pleural). Other
Gal-G2-α-CNP + H2O Gal-G2 + CNP anticoagulants (EDTA, Citrate, Oxalate) inhibit the activity of
Urinary Amylase (U/h) = (90 x 200) / (2 x 1000) = 9 U/h
Amylase.
REAGENTS Serum or Plasma: stable for 7 days at 15 to 30°C, 2 months
Number 1 - Buffered Substrate - Store between 2 and 8ºC. at 2 to 8°C and 1 year at -20°C. Amylase clearance / creatinine clearance ratio
Contains: MES buffer < 200 mmol/L, Gal-G2-α-CNP < 5 mmol/L, Urine: stable for 2 days at 15 to 30°C, 10 days at 2 to 8°C and Evaluation of the amylase clearance / creatinine clearance
activators, stabilizers and preservative. 3 weeks at -20°C. Gather in the range of 2 to 24 hours. ratio is important for determining the diagnosis of acute
Cavitary fluids (ascitic, duodenal and pleural): Stable 7 days pancreatitis. To define the clearance ratio (Amylase /
at -20°C. Creatinine) of the patient, amylase activity and creatinine
PRESENTATION
concentration in serum and a urine sample should be
Presentation Reagent Nº 1 PROCESS DESCRIPTION determined.
Equation:
1 3 x 20 mL
REAGENTS PREPARATION Urine Amylase (U/L) x Serum Creatinine
2 5 x 20 mL The Working Reagent is ready for use.
Ratio (mg/dL)
3 5 x 40 mL x 100
The calibration stability of the Amylase Kinetic kit installed on (%) = Serum Amylase (U/L) x Urine Creatine
refrigerated equipment is at least 4 weeks. This stability may (mg/dL)
EQUIPMENTS AND OPERATIONAL INPUTS vary depending on the conditions of the reagent, equipment
Thermostated spectrophotometer, pipettes, watch or and environment. Therefore, it is suggested to follow the For an average variation in absorbance at 405 nm greater
stopwatches, test tubes, Biocontrol N, Biocontrol P Bioclin product performance using control sera. than 0,25, repeat the determination, diluting the sample
and Biocal Bioclin. They can be found at markets specialized with 0,85% NaCl. Multiply the result by the dilution factor.
on Laboratories of Clinical Analysis. REACTION CONDITIONS To convert the data in the International System (SI), multiply
It is indispensable the use of thermostated cuvette the result: U/L x 0,01667 = mkat/L
TRANSPORTATION AND STORAGE CONDITIONS at 37°C, light path of 1cm and reading at 405 nm.
The storage temperature should be between 2 to 8°C. PROCEDURE LIMITATIONS
The transport at temperatures up to 30°C should not exceed TECHNIQUE The specifications below are for semi-automatic equipment:
5 days. Protect from light and avoid moisture. Do not freeze. Bioclin recommends using the kit Biocal as calibrator and as The kinetic method is based on the molar absorptivity,
control serum Biocontrol N and P Bioclin kits. therefore, the readings should be performed in a
SPECIAL CARE spectrophotometer that satisfies the following conditions:
1- For professional in vitro diagnostic use only. Serum or Plasma Wavelength 405 nm
2- Strictly follow the methodology proposed to obtain Add 20 mL of sample to 1,0 mL of Buffered Substrate, Semi trajectory of the pass band 10 nm.
exact results. mix and transfer to a thermostated cuvette at Stray light less than 0,5%.
37°C. Make the initial reading, simultaneously starting the 1cm thermostated cuvette
3- Water used in material cleaning must to be recent and free
timer. Repeat the readings at 1, 2 and 3 minutes. Calculate
of contaminants.
the mean difference in absorbance per minute (A/min.)
4- Saturated deionizer columns release alkaline water, many INTERFERING
and used to calculate the result.
ions, oxidizing agents and reducers that may alter the results Saliva contains amylase. Therefore, you should not pipet
significantly. Urine by mouth and avoid contact of the reagent with the skin.
5- Visible hemolysis may cause slight variations in results. Mix, measure and note the urinary volume in mL and the time The lipemia (triglycerides up to 1000 mg/dL) and bilirubin
6- Reagent Nº1 is easily contaminated by saliva. Therefore, of sample collection. Proceed dosage as described for serum. (up to 20 mg/dL) do not interfere with the methodology.
we recommend the use of masks, pears and automatic Hemoglobin up to 2,5 g/L no affect the results. Some
pipettes for handling this product. CALCULATIONS drugs may interfere with laboratory results, elevate the
7- Reagent Nº 1 contain Sodium Azide which can be irritating levels of serum amylase (morphine, meperidine codeine,
to skin and mucous membrans. Handle with care. Serum or Plasma thiazide diuretics) or decreasing, as in cases of barbiturate
8- We recommend applying the local, state and federal rules Amylase (U/L) =A/min. x 3954 poisoning.
for environmental protection, so that disposal of reagents and Results are expressed in U/L.
INTERNAL QUALITY CONTROL REPRODUCIBILITY EC REP OBELIS S.A. English 2/2
The Clinical Laboratory must have an internal quality control, The reproducibility was calculated from 40 successive
where all procedures, rules, limits and tolerance to variations Bd. Général Wahis, 53
determinations for 3 consecutive days, using 3 samples with
be clearly established. It is important to mention that all 1030 Brussels, Belgium
different concentrations, obtaining the following results:
measurement systems present a analytical variety, and it must
be monitor by the laboratory. Therefore, it is recommendable Sample 1 Sample 2 Sample 3 CUSTOMER SERVICE
the use of controls, allowing the precision and accuracy of Customer Advisory Service
Average
111,73 276,70 194,52 Phone.: 0800 0315454
the dosages. Concentration (U/L)
E-mail: sac@bioclin.com.br
Standard
TRACEABILITY 1,23 3,46 2,56
Deviation (U/L) ANVISA registration for Amylase Kinetic kit: 10269360079
The kit calibration can be made using the theoretical
calibration factor based on the molar absorptivity of the Coefficient of
1,10 1,25 1,32
2-Cloro-4-Nitrofenol, or through the BIOCAL calibrator. Variation (%) Review: October/2019
Bioclin recommends the usage of the BIOCAL calibrator
which is traceable to the reference material IRMM/IFCC-456. Sensitivity
The sensitivity was calculated from 40 determinations of a
REFERENCE VALUES sample free of Amylase. The average found was of
The reference values in U/L for this method were obtained 2,23 U/L with standard deviation of 0,42 U/L. The sensitivity,
by determining the α-Amylase in healthy populations of males which indicates the method detection limit, corresponds the
and females in various age groups. average plus 3 times the standard deviation and is equal
Serum: < 125 U/L to 3,49 U/L.
Urine: < 450 U/L or < 30 U/h
Linearity
Amylase clearance / creatinine clearance ratio: 1,0 to 4,0 % The reaction is linear up to 2000 U/L.
DIAGNOSTIC SIGNIFICANCE
These values should be used as guidelines, each laboratory
The Amylase, predominantly of pancreatic and salivary,
should establish its range of reference values, according to
is normally present in blood and urine in small quantities.
the population served.
Increases rapidly in plasma after the onset of acute UNIVERSAL SYMBOLOGY
The results provided by this kit must be interpreted by the pancreatitis, where there is a parallel increase in urinary
medical professional responsible, not being the only criterion amylase.
for the determination of diagnosis and/or treatment of the Elevations are also found in mesenteric infarction,
patient. perforated gastric ulcer, carcinoma of the head of the pancreas,
mumps, kidney failure, diabetic acidosis. Decreased plasma
PRODUCT PERFORMANCE levels are observed in hepatitis, liver cirrhosis, toxemia of
QUALITY CONTROL pregnancy, eclampsia, pancreatic carcinoma.
Coefficient of
0,95 0,91 0,74 CEP 31565-130 - Belo Horizonte - MG - Brasil
Variation (%)
Phone.: +55 (31) 3439.5454 - Fax: +55 (31) 3439.5455 DO NOT USE IF
KEEP AWAY
E-mail: bioclin@bioclin.com.br PANTONE
EC 654
FROM REP PANTONE 5435
SUNLIGHT EC REP PACKAGE IS
DAMAGED
CNPJ: 19.400.787/0001-07 - Made in Brazil